Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Dibutyl Succinate

Dibutyl Succinate

141-03-7

DISCOVER
Donepezil Related Compound A

Donepezil Related Compound A

145546-80-1

DISCOVER
Desbenzyl donepezil HCl

Desbenzyl donepezil HCl

120013-39-0

DISCOVER
2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic Acid

2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic Acid

197010-25-6

DISCOVER
rac-(cis/trans) Donepezil N-Oxide

rac-(cis/trans) Donepezil N-Oxide

120013-84-5

DISCOVER
Deoxy Donepezil HCl

Deoxy Donepezil HCl

1034439-57-0

DISCOVER
Donepezil Benzyl Bromide

Donepezil Benzyl Bromide

844694-85-5

DISCOVER
Dehydrodeoxy Donepezil

Dehydrodeoxy Donepezil

120013-45-8

DISCOVER
Hydroxy Donepezil

Hydroxy Donepezil

197010-20-1

DISCOVER
Desisobutyl-benzylsibutramineHCl

Desisobutyl-benzylsibutramineHCl

NA

DISCOVER
Dichloroisoeverninic acid

Dichloroisoeverninic acid

4101-80-8

DISCOVER
Diclazuril-methyl

Diclazuril-methyl

103337-71-9

DISCOVER